**Title: Advancing Precision Medicine: A Comprehensive Review of Single-Cell Multi-Omics, CRISPR Therapeutics, and Cardiovascular Pathologies**
**标题：推进精准医疗：单细胞多组学、CRISPR疗法与心血管病理学的全面综述**

---

### Introduction 
Modern biomedical research is undergoing a paradigm shift driven by high-throughput multi-omics, advanced gene-editing technologies, and large-scale clinical data analysis. This literature review synthesizes recent advancements across several critical domains, drawing strictly from a curated corpus of 133 academic papers. We explore the rapidly evolving landscapes of single-cell proteomics and transcriptomics, the complex dynamics of cell-cell communications within spatial microenvironments, and the transformative impact of CRISPR-mediated genome engineering. Furthermore, we analyze the functional implications of genetic variants and somatic mutations in aging and disease, and conclude with a focused examination of clinical cardiovascular research, particularly regarding aortic interventions and stroke management. Together, these studies highlight the synergistic integration of computational biology, molecular engineering, and clinical phenotyping in the era of precision medicine.

### 简介
现代生物医学研究正经历一场由高通量多组学、先进基因编辑技术和大规模临床数据分析驱动的范式转变。本篇文献综述严格基于所提供的133篇学术论文，综合阐述了多个关键领域的最新进展。我们将探讨单细胞蛋白质组学和转录组学快速发展的现状，空间微环境内细胞间通讯的复杂动态，以及CRISPR介导的基因组工程所带来的变革性影响。此外，我们分析了遗传变异和体细胞突变在衰老与疾病中的功能意义，最后重点审视了临床心血管研究（特别是主动脉干预和卒中管理）的进展。这些研究共同突显了在精准医疗时代，计算生物学、分子工程学与临床表型分析的协同整合。

---

### Thematic Sections / 主题板块

#### 1. Single-Cell Proteomics and Multi-Omics Trajectories
The ability to profile cellular heterogeneity at unprecedented resolution has been revolutionized by single-cell multi-omics. While single-cell RNA sequencing (scRNA-seq) provides robust transcriptomic landscapes, inferring stochastic dynamics from static snapshots remains mathematically challenging, a problem Dou et al. [1] address using biophysical Neural ODEs. Beyond transcriptomics, single-cell proteomics (SCP) has emerged as a crucial frontier. Orsburn [34] highlights the practical applications of SCP, noting its rapid development in sample preparation and informatics. To manage the immense complexity of SCP data, Anwar et al. [23] propose a unified framework for batch correction and missing data handling in large-scale mass spectrometry proteomics. Furthermore, the integration of multimodal data is essential for charting cellular dynamics; Wang et al. [6] discuss computational approaches for multimodal lineage tracing, linking heritable lineage information with multi-omics to decode organismal development and disease progression.

#### 1. 单细胞蛋白质组学与多组学轨迹
以前所未有的分辨率分析细胞异质性的能力，已因单细胞多组学技术的发展而发生革命性变化。尽管单细胞RNA测序（scRNA-seq）提供了强大的转录组图谱，但从静态快照中推断随机动态在数学上仍然具有挑战性，Dou等人 [1] 利用生物物理神经常微分方程（Neural ODEs）解决了这一问题。除转录组学外，单细胞蛋白质组学（SCP）已成为一个关键前沿。Orsburn [34] 强调了SCP的实际应用，指出其在样本制备和信息学方面的快速发展。为了管理SCP数据的巨大复杂性，Anwar等人 [23] 提出了一种在大规模质谱蛋白质组学中进行批次校正和缺失数据处理的统一框架。此外，多模态数据的整合对于描绘细胞动态至关重要；Wang等人 [6] 探讨了多模态谱系追踪的计算方法，将可遗传的谱系信息与多组学相结合，以解码生物体发育和疾病进展。

#### 2. Spatial Architecture and Cell-Cell Communications
Biological functions are heavily dictated by their spatial context and the signaling networks between distinct cell types. Lu et al. [25] propose a self-supervised graph learning framework to decipher spatial domains and cell heterogeneity by combining spatial multi-omics data. Evaluating these interactions computationally requires standardized benchmarks, as established by the SpatialCCCbench framework for assessing spatial cell-cell communication methods [35]. The mechanistic relevance of these communications is evident in disease models; for instance, Wang et al. [58] identified a CD44-dependent mechanism enhancing astrocyte-glial crosstalk and autophagic activity in Alzheimer's disease using single-nucleus RNA-seq. Additionally, Jia et al. [117] underscore the role of vesicle-associated membrane proteins (VAMPs) in regulating vesicular trafficking and intercellular communication during aging-related diseases, demonstrating that cell-cell communications serve as viable therapeutic targets.

#### 2. 空间架构与细胞间通讯
生物学功能在很大程度上取决于其空间背景以及不同细胞类型之间的信号网络。Lu等人 [25] 提出了一种自监督图学习框架，通过结合空间多组学数据来解码空间结构域和细胞异质性。在计算上评估这些相互作用需要标准化的基准测试，正如SpatialCCCbench框架为评估空间细胞间通讯方法所建立的标准 [35]。这些通讯机制在疾病模型中具有明显的生物学相关性；例如，Wang等人 [58] 利用单核RNA测序发现了一种依赖CD44的机制，该机制在阿尔茨海默病中增强了星形胶质细胞与胶质细胞的交互作用及自噬活性。此外，Jia等人 [117] 强调了囊泡相关膜蛋白（VAMPs）在衰老相关疾病期间调节囊泡运输和细胞间通讯的作用，表明细胞间通讯可作为可行的治疗靶点。

#### 3. CRISPR-Mediated Genome Engineering and Perturbations
CRISPR-Cas systems have transitioned from basic research tools to foundational therapeutic modalities. Peng et al. [2] review methodologies and applications of multiplex genome engineering, while Ramachandran et al. [3] introduce CleanFinder, a scalable framework for comprehensive genome editing analysis. High-throughput CRISPR screens have dramatically expanded our functional annotation of the genome. Liang et al. [7] utilized RNA-targeting CRISPR-Cas13 screens to probe the essentiality of ~5,500 long noncoding RNAs (lncRNAs), identifying hundreds of context-specific essential transcripts. CRISPR technologies are also being harnessed for antiviral therapeutics, as shown by Li et al. [13], who identified SPART as a restriction factor against orthoflaviviruses using a genome-wide CRISPR activation screen. In targeted clinical applications, Klijnhout et al. [10] optimize CRISPR/Cas9 ribonucleoprotein delivery for genetic engineering in human keratinocytes, and Kongsomboonchoke et al. [63] demonstrate efficient AAV-mediated CRISPR/Cas9 suppression of HBV replication.

#### 3. CRISPR介导的基因组工程与扰动
CRISPR-Cas系统已从基础研究工具过渡为基础治疗手段。Peng等人 [2] 回顾了多重基因组工程的方法与应用，而Ramachandran等人 [3] 介绍了CleanFinder，这是一种用于全面基因组编辑分析的可扩展框架。高通量CRISPR筛选极大地扩展了我们对基因组的功能注释。Liang等人 [7] 利用靶向RNA的CRISPR-Cas13筛选技术，探测了约5500个长链非编码RNA（lncRNAs）的必需性，识别出数百个具有环境特异性的必需转录本。CRISPR技术也被用于抗病毒治疗，正如Li等人 [13] 所展示的，他们通过全基因组CRISPR激活筛选确定了SPART作为正黄病毒的限制因子。在靶向临床应用方面，Klijnhout等人 [10] 优化了用于人角质形成细胞基因工程的CRISPR/Cas9核糖核蛋白递送，Kongsomboonchoke等人 [63] 则展示了AAV介导的CRISPR/Cas9对HBV复制的高效抑制。

#### 4. Dissecting Genetic Variants and Somatic Mutations
Understanding the phenotypic consequences of genetic variants and somatic mutations is central to unravelling complex diseases. Buralkin et al. [30] propose scDeepVariant, a deep learning framework for accurate germline variant calling directly from scRNA-seq data. At the epigenetic level, Mallory et al. [5] investigate the chromatin architectures underlying plasmid-based assays to better understand regulatory variant effects. The impact of specific mutations is explored by Pratumkaew et al. [8], who modeled hemolytic anemia driven by compound heterozygous KLF1 mutations using induced pluripotent stem cells, and Roman [9], who compared Prime Editing with HIROS for correcting cardiomyopathy-causing mutations. Furthermore, aging introduces complex mutational burdens; Ehlert et al. [32] characterize how the aging genome exhibits organized vulnerability to somatic mutations, linking baseline genomic instability to physiological decline. 

#### 4. 剖析遗传变异与体细胞突变
了解遗传变异和体细胞突变的表型后果是解开复杂疾病机制的核心。Buralkin等人 [30] 提出了scDeepVariant，这是一种用于直接从scRNA-seq数据中进行准确生殖细胞变异调用的深度学习框架。在表观遗传层面，Mallory等人 [5] 研究了基于质粒的分析底层的染色质架构，以更好地理解调控变异效应。特定突变的影响得到了深入探讨，例如Pratumkaew等人 [8] 利用诱导多能干细胞建立了由复合杂合KLF1突变驱动的溶血性贫血模型，而Roman [9] 则比较了先导编辑（Prime Editing）与HIROS在纠正扩张型心肌病致病突变中的效果。此外，衰老会带来复杂的突变负荷；Ehlert等人 [32] 描述了衰老基因组如何表现出对体细胞突变的结构性易感性，将基线基因组不稳定性与生理衰退联系起来。

#### 5. Aortic Pathologies, Stroke, and Endovascular Interventions
The dataset highlights a profound emphasis on neurological and cardiovascular outcomes, particularly the relationship between aortic structural interventions, large vessel occlusions (LVO), and stroke. Bou Dargham et al. [4] conducted a meta-analysis on stroke risk following bioprosthetic aortic valve replacement in patients with aortic stenosis, emphasizing the need for optimized perioperative anticoagulation. In the realm of acute stroke management, optimizing recanalization is paramount. Wang et al. [18] demonstrate that thrombolysis-to-puncture time significantly influences the differential effects of tenecteplase versus alteplase in LVO. Further, Zhang et al. [17] compare endovascular thrombectomy with standard medical management for acute anterior cerebral artery occlusion. The integrity of the blood-brain barrier also plays a critical role in these patients, as detailed by Leigh et al. [19], who examined core blood-brain barrier disruption in LVO cohorts. The intricacies of vascular hemodynamics are further contextualized by Bagnato et al. [15], examining dual-circulation hemodynamic failure originating from critical internal carotid stenosis.

#### 5. 主动脉病理、卒中与血管内介入治疗
文献数据集深刻强调了神经与心血管结局，特别是主动脉结构性干预、大血管闭塞（LVO）与卒中之间的关系。Bou Dargham等人 [4] 针对主动脉瓣狭窄患者在生物制主动脉瓣置换术后的卒中风险进行了荟萃分析，强调了优化围手术期抗凝治疗的必要性。在急性卒中管理领域，优化血管再通至关重要。Wang等人 [18] 证明，溶血至穿刺时间显著影响替奈普酶与阿替普酶在LVO中的差异性疗效。此外，Zhang等人 [17] 比较了急性大脑前动脉闭塞患者的血管内取栓术与标准药物治疗。血脑屏障的完整性在这些患者中也起着关键作用，正如Leigh等人 [19] 在研究LVO队列中核心血脑屏障破坏时所详细阐述的那样。Bagnato等人 [15] 则进一步结合重度颈内动脉狭窄引发的双循环血流动力学衰竭，探讨了血管血流动力学的复杂性。

---

### Future Directions and Conclusion 
The convergence of omics technologies, genomic engineering, and clinical phenotyping signifies a transition toward profoundly precise biological mechanistic models. Future research is poised to increasingly integrate AI/ML paradigms—such as foundation models for tumor genomics [108] or large language model agents for biomedical tasks [41]—to map complex variant-to-phenotype relationships. Specifically, the field will benefit from advancing spatial cell-cell communication networks into 3D dynamic models, translating CRISPR therapeutics from cellular assays into robust clinical solutions, and leveraging multi-omics to risk-stratify cardiovascular and aortic events with molecular precision. Collectively, the reviewed literature lays a formidable foundation for next-generation translational medicine.

### 总结与展望
组学技术、基因组工程与临床表型分析的融合，标志着向极其精确的生物机制模型转变的趋势。未来的研究必将越来越多地整合人工智能/机器学习范式——例如用于肿瘤基因组学的基础模型 [108] 或用于生物医学任务的大语言模型智能体 [41]——以绘制复杂的“变异-表型”关系图谱。具体而言，该领域将受益于把空间细胞间通讯网络推向三维动态模型，将CRISPR疗法从细胞实验转化为稳健的临床方案，以及利用多组学以分子级别的精度对心血管和主动脉事件进行风险分层。总而言之，本文综述的文献为下一代转化医学奠定了坚实的基础。